Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTBP2 | P56545 | 13/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | CES2 | O00748 | 1/20 | 0.54 |
| ▸ | CES1 | P23141 | 1/20 | 0.54 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28552907 | 1.00 | CTBP2 (1.00) | CTBP2CYP1A2CYP2C19CES2CES1 | |
| SCHEMBL7823733 | 0.88 | CTBP2 (0.77) | CTBP2CYP1A2CYP2C19CA1CA2 | |
| SCHEMBL7823734 | 0.88 | CTBP2 (0.77) | CTBP2CYP1A2CYP2C19CA1CA2 | |
| SCHEMBL3084459 | 0.86 | CTBP2 (0.75) | CTBP2CES2CES1AKR1B1CA1 | |
| SCHEMBL3084456 | 0.86 | CTBP2 (0.75) | CTBP2CES2CES1AKR1B1CA1 | |
| SCHEMBL3084457 | 0.86 | CTBP2 (0.75) | CTBP2CES2CES1AKR1B1CA1 | |
| SCHEMBL11282864 | 0.83 | CTBP2 (1.00) | CTBP2CYP1A2CYP2C19CA1CA2 | |
| SCHEMBL11282868 | 0.83 | CTBP2 (1.00) | CTBP2CYP1A2CYP2C19CA1CA2 | |
| SCHEMBL31264411 | 0.83 | CTBP2 (0.71) | CTBP2CYP2C19CES2CES1AKR1B1 | |
| SCHEMBL7877787 | 0.83 | CTBP2 (0.71) | CTBP2CES2CES1AKR1B1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240241437-A1 | SEMICONDUCTOR PHOTORESIST COMPOSITION AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | SAMSUNG SDI CO., LTD. (KR) | 2024-07-18 | — | — | US | disclosed |
| US-20240241437-A1 | SEMICONDUCTOR PHOTORESIST COMPOSITION AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | SAMSUNG SDI CO., LTD. (KR) | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240241437-A1 | SEMICONDUCTOR PHOTORESIST COMPOSITION AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | BPNT1, NISCH, LCP1 | CTBP2 1620/4885CYP1A2 954/4885CYP2C19 1953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.